The Business Research Company’s Neurotrophic Keratitis Treatment Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Neurotrophic Keratitis Treatment Global Market Report 2023 evaluates neurotrophic keratitis treatment market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12968&type=smp
The global neurotrophic keratitis treatment market is expected to grow from the neurotrophic keratitis treatment market size has grown strongly in recent years. It will grow from $4.7 billion in 2023 to $5.1 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increased diagnoses, increasing injury and surgical procedures, rising research and development, global healthcare infrastructure.The neurotrophic keratitis treatment market size is expected to see strong growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%.
The growing prevalence of eye diseases is expected to propel the growth of the neurotrophic keratitis treatment market going forward. Eye diseases are a wide range of medical problems and disorders that affect the structure and function of the eyes. Neurotrophic keratitis can aid in the improvement of corneal sensation, the promotion of healing, the prevention of infection, and the relief of pain and suffering. For instance, in March 2022, according to the reports shared by Eye Care One, a US-based eyecare career development services platform, it was estimated that 35 million US people will suffer from dry eye disease (DED) in 2022 and the prevalence will rise yearly. Furthermore, in March 2021, according to the Eyes of the World Foundation, a Spain-based non-profit organization, there will be 1.1 billion people with vision loss in 2021, which is estimated to increase to 1.7 billion by 2050. Therefore, the growing prevalence of eye diseases is driving the growth of the neurotrophic keratitis treatment market.
Get More Information On The Neurotrophic Keratitis Treatment Market Report:
The neurotrophic keratitis treatment market segments in the report are:
1) By Treatment: Topical Antibiotics, Recombinant Human Nerve Growth Factor (rhNGF), Amniotic Membrane Transplantation, Keratoplasty, Other Treatments
2) By Route of Administration: Oral, Topical, Other Routes of Administration
3) By Application: Stage I, Stage II, Stage III
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
The table of contents in TBRC’s neurotrophic keratitis treatment market report includes:
1. Executive Summary
2. Neurotrophic Keratitis Treatment Market Characteristics
3. Neurotrophic Keratitis Treatment Market Trends And Strategies
4. Neurotrophic Keratitis Treatment Market – Macro Economic Scenario
5. Global Neurotrophic Keratitis Treatment Market Size and Growth
.
.
.
26. South America Neurotrophic Keratitis Treatment Market
27. Brazil Neurotrophic Keratitis Treatment Market
28. Middle East Neurotrophic Keratitis Treatment Market
29. Africa Neurotrophic Keratitis Treatment Market
30. Neurotrophic Keratitis Treatment Market Competitive Landscape And Company Profiles
Top Major Players:
- Eyevance Pharmaceuticals LLC
- Grand Pharma Co. Ltd
- Walgreen Co
- Pfizer Inc
- Johnson and Johnson
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
